logo
Select company
Select metric
$ 688.49KInterest Expense
VS
Market
59
Sector
43
Industry
30
History
21
$ 3.96Close
$ 1.67 - $ 9.13 52-Week Range
Ticker Information

Ticker

QLGN

Company Name

QUALIGEN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

QUALIGEN THERAPEUTICS INC - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

QLGN - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ 688.49K
3/31/2025$ 846K
12/31/2024$ 908.94K
9/30/2024$ 1.04M
6/30/2024$ 1M
3/31/2024$ 1.12M
12/31/2023$ 1.52M
9/30/2023$ 1.32M
6/30/2023$ 948.3K
3/31/2023$ 570.88K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • QUALIGEN THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. stands at $ 58.08K.
  • Over the past 5 years, QUALIGEN THERAPEUTICS INC's average Int. Exp. has been $ 505.29K.
  • The median Int. Exp. for QUALIGEN THERAPEUTICS INC during this period was $ 383.28K
  • QUALIGEN THERAPEUTICS INC reached its highest Int. Exp. over the past 5 years at $ 1.52M.
  • The lowest Int. Exp. recorded by QUALIGEN THERAPEUTICS INC in the same timeframe $ -46.9K

Similar metrics to Int. Exp.:

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

QLGN - Interest Expense, Last 5 years

$ -46.9K

Minimum

Sep 30, 2021

$ 1.52M

Maximum

Dec 31, 2023

$ 505.29K

Average

$ 383.28K

Median

Int. Exp. Benchmark Analysis

 The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.75M with a standard deviation of $ 5.5M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.72K
min$ -15.41M
max$ 22.87M
average$ 2.75M
median$ 17.64K
std$ 5.5M